Natural versus drug-induced resistance in Schistosoma mansoni infection.
about
Current status of vaccines for schistosomiasisTranscriptional changes in Schistosoma mansoni during early schistosomula development and in the presence of erythrocytesSerological screening of the Schistosoma mansoni adult worm proteomeAn immunomics approach to schistosome antigen discovery: antibody signatures of naturally resistant and chronically infected individuals from endemic areasVaccines to combat the neglected tropical diseases.Cytokine responses to Schistosoma haematobium in a Zimbabwean population: contrasting profiles for IFN-gamma, IL-4, IL-5 and IL-10 with ageTrick or treat: the role of vaccines in integrated schistosomiasis control.Effect of treating Schistosoma haematobium infection on Plasmodium falciparum-specific antibody responses.Rapid induction of IgE responses to a worm cysteine protease during murine pre-patent schistosome infectionUse of humanised rat basophilic leukaemia cell line RS-ATL8 for the assessment of allergenicity of Schistosoma mansoni proteins.Lipid core peptide targeting the cathepsin D hemoglobinase of Schistosoma mansoni as a component of a schistosomiasis vaccine.Alterations in peripheral blood B cell subsets and dynamics of B cell responses during human schistosomiasis.Structure-function analysis of apical membrane-associated molecules of the tegument of schistosome parasites of humans: prospects for identification of novel targets for parasite control.Upregulated expression of cytotoxicity-related genes in IFN-γ knockout mice with Schistosoma japonicum infection.Fusion protein comprised of the two schistosomal antigens, Sm14 and Sm29, provides significant protection against Schistosoma mansoni in murine infection modelOf monkeys and men: immunomic profiling of sera from humans and non-human primates resistant to schistosomiasis reveals novel potential vaccine candidates.Protective Potential of Antioxidant Enzymes as Vaccines for Schistosomiasis in a Non-Human Primate Model.Toxocara canis mucins among other excretory-secretory antigens induce in vitro secretion of cytokines by mouse splenocytesEvidence of long term benefit of morbidity reduction due to praziquantel treatment against schistosoma mansoni in kigungu fishing village in entebbe, Uganda.Geohelminth infections: a review of the role of IgE and assessment of potential risks of anti-IgE treatment.Glycoconjugates in host-helminth interactionsDevelopment of a schistosomiasis vaccine.Cross-reactivity of Schistosoma mansoni cytosolic superoxide dismutase, a protective vaccine candidate, with host superoxide dismutase and identification of parasite-specific B epitopes.Longitudinal analysis of antigen specific response in individuals with Schistosoma mansoni infection in an endemic area of Minas Gerais, Brazil.Protective effects of membrane-anchored and secreted DNA vaccines encoding fatty acid-binding protein and glutathione S-transferase against Schistosoma japonicum.The protective role of antibody responses during Mycobacterium tuberculosis infection.Parasite glycans and antibody-mediated immune responses in Schistosoma infection.Treatment of Schistosoma mansoni with miltefosine in vitro enhances serological recognition of defined worm surface antigens.Evaluation of protective immune response in mice by vaccination the recombinant adenovirus for expressing Schistosoma japonicum inhibitor apoptosis protein.Chemotherapy-induced, age-related changes in antischistosome antibody responses.The antibody responses to adult-worm antigens of Schistosoma haematobium, among infected and resistant individuals from an endemic community in southern Ghana.Schistosoma mansoni TOR is a tetraspanning orphan receptor on the parasite surface.Tetraspanins on the surface of Schistosoma mansoni are protective antigens against schistosomiasis
P2860
Q24657733-D348D975-8784-4E0A-846F-4CD27347CF36Q28472811-EFAFCB32-D386-4017-907B-41AE42E1756AQ28541191-B69A0735-1F31-4DBA-9CF5-8AD27867540CQ28541675-C9DA0359-D388-4E76-AAFA-ED1C139125ECQ30425005-825236D5-3164-4A86-B26C-FA774EF3D1E0Q33307616-BD72577E-6C61-4C1B-9FFB-6240B389F489Q33346303-83C434F8-C793-46D5-B2C3-7565512C37FBQ33385010-E8D5D057-5066-4BAF-A100-E195BEAA4659Q33747036-5BE53B8B-B817-471B-B317-B2964B5E557FQ34256750-6C0137D3-EBA5-420F-9D57-255E524C3ECBQ34290786-0A09D0BF-D1A5-414A-AEE9-AC41360F0823Q34626114-50740513-ADC0-4995-99E4-3AA6C708F833Q35223902-D63C2261-0C6F-4DA2-A8B2-197D4C2A266BQ35251136-F4D6C986-E7D0-4BC5-B889-CEAEE769CCB3Q35319744-F031C98A-0D0C-4AC8-9675-CD2680DC963DQ35569944-353E2A5E-B801-4F4E-B0DC-BF37974FFB54Q35665650-4A7A1417-C3DF-4E9E-92CD-D67476CC2E1DQ35957718-1618695F-B512-4256-830E-1CAF8EDA9FB3Q36398139-105C8449-DE1A-4972-A4DF-5B03D451F6C9Q37100297-BDA24263-B8B5-497C-ACCB-84B92E89F353Q37126736-0129D5D7-B35F-4807-99AD-5D7D249D0BDBQ37350747-63397646-89FA-4748-956A-EC378BA9B536Q37427225-A28A5B77-C23A-4973-80FE-4D088DF45B10Q37464180-26217264-AAA0-47BE-9ECC-F20A3FCB10A9Q37510256-29028608-00B3-46AC-AED3-B0EFEC6030EEQ37552026-0FFAB801-D216-4A3F-A894-5372D41E802DQ37994231-90C9EAFA-3727-41AB-962E-035E7270629AQ40079529-391226AA-925D-4E66-BE9F-07348D172269Q41755834-E2E67EEC-A336-40DE-B779-3E5945732963Q44468424-306206BA-341A-4227-9B0C-02FE7751DCEFQ47229328-A0845EBA-3AEC-40DF-9AFA-2E8AAE6DFEA9Q51772015-ECA50272-3826-42D6-AB66-18A934BC8DF6Q59278433-8E6A3647-A40F-459D-8338-EB85CAD45ACA
P2860
Natural versus drug-induced resistance in Schistosoma mansoni infection.
description
2000 nî lūn-bûn
@nan
2000 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2000 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2000年の論文
@ja
2000年論文
@yue
2000年論文
@zh-hant
2000年論文
@zh-hk
2000年論文
@zh-mo
2000年論文
@zh-tw
2000年论文
@wuu
name
Natural versus drug-induced resistance in Schistosoma mansoni infection.
@ast
Natural versus drug-induced resistance in Schistosoma mansoni infection.
@en
Natural versus drug-induced resistance in Schistosoma mansoni infection.
@nl
type
label
Natural versus drug-induced resistance in Schistosoma mansoni infection.
@ast
Natural versus drug-induced resistance in Schistosoma mansoni infection.
@en
Natural versus drug-induced resistance in Schistosoma mansoni infection.
@nl
prefLabel
Natural versus drug-induced resistance in Schistosoma mansoni infection.
@ast
Natural versus drug-induced resistance in Schistosoma mansoni infection.
@en
Natural versus drug-induced resistance in Schistosoma mansoni infection.
@nl
P2093
P1476
Natural versus drug-induced resistance in Schistosoma mansoni infection.
@en
P2093
Corrêa-Oliveira R
Gazzinelli G
P304
P356
10.1016/S0169-4758(00)01740-3
P577
2000-09-01T00:00:00Z